Related Experiment Videos
A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences.
Mark A Jensen1, Mia Coetzer, Angélique B van 't Wout
1Department of Microbiology, University of Washington, Seattle, WA, USA. mark.jensen@emory.edu
Journal of Virology
|April 28, 2006
Summary
A new C-PSSM predictor accurately identifies CXCR4 variants in HIV-1 subtype C infections, improving understanding of coreceptor usage and disease progression. This method offers a faster, cheaper alternative for identifying CXCR4 variants in subtype C.
Area of Science:
- Virology
- Bioinformatics
- Genetics
Background:
- Human immunodeficiency virus type 1 (HIV-1) subtype C causes over 50% of global infections.
- CXCR4 coreceptor usage in HIV-1 subtype C is less understood than in subtype B, despite its association with disease progression.
- Accurate prediction of CXCR4 variants is crucial for understanding HIV-1 subtype C pathogenesis.
Purpose of the Study:
- To develop and validate a genotypic prediction method for CXCR4 coreceptor usage in HIV-1 subtype C.
- To compare the performance of the new method against existing prediction strategies.
Main Methods:
- A Position-Specific Scoring Matrix (PSSM) approach, previously successful for subtype B, was adapted for subtype C V3 loop sequences.
- A training set of 279 subtype C sequences with known phenotypes (CCR5+ NSI and CXCR4+ SI) was used to derive the C-PSSM predictor.
- Performance was evaluated using bootstrapping and leave-one-out cross-validation, with a separate validation set.
Main Results:
- The C-PSSM predictor achieved a specificity of 94% and a sensitivity of 75% on the training data.
- The method demonstrated significantly higher sensitivity (75%) compared to other methods (e.g., charged residue method at 47.8%).
- Validation on a unique subtype C set yielded a specificity of 83% and sensitivity of 83%.
Conclusions:
- The developed C-PSSM predictor is a reliable and sensitive tool for predicting CXCR4 coreceptor usage in HIV-1 subtype C.
- This bioinformatic approach offers a rapid and cost-effective means to identify CXCR4 variants, aiding research into subtype C progression.
- The findings suggest that specific genetic sites influencing coreceptor usage may differ between HIV-1 subtypes.